PKS-17045-44772 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2022-04-16
Dose 1 — Pfizer-BioNTech
2022-05-14
Dose 2 — Pfizer-BioNTech
2022-06-23
Registered in v-safe
2022-06-23
Health check-in — day 35, dose 2, dependent
Feeling: Poor

Adult check-in
2022-06-25
Survey response — day 42, dose 2, dependent
MedDRA: Fatigue, Nausea, Ocular hyperaemia, Pyrexia, Viral infection — Feeling: Good · Be unable to work or attend school

Free text: Fever, bloodshot eyes, nausea, and fatigue 5 days. Probably a virus caught from another child that threw up at the pool. Seems to be recovering, but still tired and right eye still bloodshot.

MedDRA releases: 2024-11 · check-in free text available
2022-08-13
Health check-in — 3 months, dose 2, dependent
Feeling: Good

Adult check-in
2022-11-12
Health check-in — 6 months, dose 2, dependent
Feeling: Good

Adult check-in
2023-05-14
Health check-in — 12 months, dose 2, dependent
Feeling: Good

Adult check-in

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2022-04-16	Pfizer-BioNTech	No
2	2022-05-14	Pfizer-BioNTech	No

Free text

Release 12 — day 42, dose 2, dependent

2022-06-25

Symptoms: Fever, bloodshot eyes, nausea, and fatigue 5 days. Probably a virus caught from another child that threw up at the pool. Seems to be recovering, but still tired and right eye still bloodshot.

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Fatigue	·	·	✓
SD	Nausea	·	·	✓
SD	Ocular hyperaemia	·	·	✓
SD	Pyrexia	·	·	✓
SD	Viral infection	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release